Fiduciary Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,033
Closed -$1.21M 179
2017
Q3
$1.21M Sell
19,033
-12,500
-40% -$777K 0.27% 83
2017
Q2
$2.01M Sell
31,533
-12,403
-28% -$779K 0.46% 61
2017
Q1
$2.9M Sell
43,936
-6,166
-12% -$424K 0.69% 47
2016
Q4
$3.45M Sell
50,102
-18,563
-27% -$1.33M 0.89% 41
2016
Q3
$4.84M Buy
68,665
+7,755
+13% +$580K 1.31% 21
2016
Q2
$4.62M Sell
60,910
-1,580
-3% -$116K 1.28% 24
2016
Q1
$4.29M Buy
62,490
+1,777
+3% +$128K 1.24% 26
2015
Q4
$5.31M Buy
60,713
+1,684
+3% +$144K 1.58% 16
2015
Q3
$4.78M Buy
59,029
+815
+1% +$71K 1.59% 11
2015
Q2
$5.18M Buy
+58,214
New +$5.09M 1.63% 9

Other funds holding ESRX

Fiduciary Group's ESRX Position: Q4 2017 in Review

Fiduciary Group sold out of Express Scripts Holding Company (ESRX) in Q4 2017, closing a stake of 19,033 shares — an estimated $1.21M sold.

Fiduciary Group first reported a position in ESRX in Q2 2015 and held it in 10 quarters. The position peaked at $5.31M in Q4 2015. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q4 2017.

  • Fiduciary Group reported no remaining Express Scripts Holding Company position as of Q4 2017 after selling out during the quarter.
  • Fiduciary Group sold 19,033 Express Scripts Holding Company shares in Q4 2017, an estimated $1.21M.
  • Fiduciary Group first reported a position in Express Scripts Holding Company in Q2 2015 and held it in 10 quarters.
  • Fiduciary Group's Express Scripts Holding Company position peaked at $5.31M in Q4 2015.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2017.

Based on Fiduciary Group's 13F filing for Q4 2017, filed 2 Feb 2018.